Medical University Of Gdansk
- Address
- Ul. Debinki 7, 80-211 Gdansk, Poland
Medical University of Gdansk - Cardiovascular and Pediatric Research Center
The Medical University of Gdansk is a distinguished clinical research institution with demonstrated expertise in cardiovascular interventions and pediatric specialty care. The center conducts advanced investigations in acute coronary syndrome management and perioperative cardiac protection, focusing on optimizing antiplatelet strategies and preventing myocardial injury in surgical patients.
- Cardiovascular research including acute coronary syndrome treatment de-escalation strategies and myocardial injury prevention
- Pediatric nephrology with focus on nephrotic syndrome and novel rituximab treatment protocols
- Pediatric oncology specializing in hepatoblastoma and hepatocellular carcinoma with individualized treatment approaches
- Rare genetic disorders including tuberous sclerosis complex, Dravet syndrome, and Marfan syndrome
The center demonstrates particular strength in pediatric research, investigating complex conditions such as rare epileptic syndromes, heritable thoracic aortic diseases, and primary malignant liver tumors in children. Their participation in international collaborative trials, including the Paediatric Hepatic International Tumour Trial (PHITT), reflects their commitment to advancing treatment protocols through multi-center research initiatives and developing innovative therapeutic strategies for both common and rare diseases across multiple medical specialties.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 24 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
- 1Medical University Of Gdansk3active
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Medical University Of Gdansk3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical University Of Gdansk
lock Showing 1 of 10 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase I/II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of EP0031 in Patients with Advanced RET-Altered Malignancies | Ellipses Pharma Limited | Phase I | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 24 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 3 | Unknown | 2018-03-06 | 2025-08-28 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.